Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Saved in:
Bibliographic Details
Title: Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Authors: Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Center, Marseille, France., Attard G; Research Department of Oncology, University College London, London, UK., Bjartell A; Department of Urology, Skåne University Hospital, Malmo, Sweden., Blanchard P; Department of Oncological Radiotherapy, Gustave Roussy, Université Paris Saclay, INSERM U1018 Oncostat, Villejuif, France., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Compérat E; Department of Pathology, Medical University of Vienna, Vienna, Austria., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia., Fanti S; Department of Nuclear Medicine, AOU Policlinico Sant'Orsola-Malpighi, Bologna, Italy., Fonteyne V; Department of Radiation Oncology, Ghent University, Ghent, Belgium., Foulon S; Biostatistics and Epidemiology Department, Institut Gustave Roussy, Villejuif, France., Gillessen S; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Gravis G; Institut Paoli-Calmettes, Department of Medical Oncology, Aix Marseille University, INSERM, CNRS, CRCM, Immunity and Cancer Team, Marseille, France., James ND; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK., Oprea-Lager DE; Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Ost P; Department of Radiation Oncology, Iridium Network, Wilrijk, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Padhani A; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK., Parker C; Urology Unit, The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK., Renard-Penna RM; Department of Imagery, Hôpital Pitié Salpétrière, Sorbonne Université, Paris, France., Rubin MA; Department for Biomedical Research, University of Bern, Bern, Switzerland., Saad F; Department of Surgery and Urology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Canada., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey., Tombal B; Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Tree AC; Department of Radiotherapy, The Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK., Zilli T; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Fizazi K; Department of Medical Oncology, Centre Oscar Lambret, Lille, France; Department of Oncology, University of Paris Saclay, Villejuif, France.
Corporate Authors: ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Apr; Vol. 37 (4), pp. 453-469. Date of Electronic Publication: 2025 Dec 18.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1569-8041
DOI:10.1016/j.annonc.2025.12.009